United Laboratories International Holdings Gelecekteki Büyüme
Future kriter kontrolleri 1/6
United Laboratories International Holdings kazanç ve gelirin sırasıyla yıllık 3.9% ve 6.1% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 4% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 19.5% olacağı tahmin edilmektedir.
Anahtar bilgiler
3.9%
Kazanç büyüme oranı
4.0%
EPS büyüme oranı
| Pharmaceuticals kazanç büyümesi | 10.9% |
| Gelir büyüme oranı | 6.1% |
| Gelecekteki özkaynak getirisi | 19.5% |
| Analist kapsamı | Good |
| Son güncelleme | 31 Oct 2024 |
Gelecekteki son büyüme güncellemeleri
Recent updates
These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Nov 11
The United Laboratories International Holdings Limited (HKG:3933) Stock Catapults 29% Though Its Price And Business Still Lag The Market
Oct 23Here's Why We Think United Laboratories International Holdings (HKG:3933) Is Well Worth Watching
Aug 30Improved Earnings Required Before The United Laboratories International Holdings Limited (HKG:3933) Stock's 26% Jump Looks Justified
Feb 29The United Laboratories International Holdings Limited's (HKG:3933) Low P/E No Reason For Excitement
Jan 04United Laboratories International Holdings (HKG:3933) Could Easily Take On More Debt
Dec 14With EPS Growth And More, United Laboratories International Holdings (HKG:3933) Makes An Interesting Case
Nov 26Is United Laboratories International Holdings (HKG:3933) A Risky Investment?
Aug 31Does United Laboratories International Holdings (HKG:3933) Deserve A Spot On Your Watchlist?
Aug 10United Laboratories International Holdings (HKG:3933) Has A Rock Solid Balance Sheet
Dec 23Are Investors Undervaluing The United Laboratories International Holdings Limited (HKG:3933) By 47%?
Oct 19Is United Laboratories International Holdings (HKG:3933) Using Too Much Debt?
Aug 30Is The United Laboratories International Holdings Limited (HKG:3933) A Smart Pick For Income Investors?
Mar 08The United Laboratories International Holdings (HKG:3933) Share Price Is Up 108% And Shareholders Are Boasting About It
Feb 18
The United Laboratories International Holdings Limited's (HKG:3933) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 03Did The United Laboratories International Holdings Limited (HKG:3933) Insiders Sell Shares?
Jan 19We Wouldn't Rely On United Laboratories International Holdings's (HKG:3933) Statutory Earnings As A Guide
Jan 04These 4 Measures Indicate That United Laboratories International Holdings (HKG:3933) Is Using Debt Safely
Dec 20What Type Of Shareholders Own The Most Number of The United Laboratories International Holdings Limited (HKG:3933) Shares?
Dec 07The United Laboratories International Holdings Limited (HKG:3933) Is Yielding 1.3% - But Is It A Buy?
Nov 23Kazanç ve Gelir Büyüme Tahminleri
| Tarih | Gelir | Kazançlar | Serbest Nakit Akışı | Faaliyetlerden Nakit | Avg. Analist Sayısı |
|---|---|---|---|---|---|
| 12/31/2026 | 16,393 | 3,206 | N/A | 3,756 | 7 |
| 12/31/2025 | 15,382 | 3,015 | N/A | 3,545 | 8 |
| 12/31/2024 | 14,664 | 2,928 | N/A | 3,545 | 8 |
| 6/30/2024 | 14,009 | 2,908 | 1,420 | 3,088 | N/A |
| 3/31/2024 | 13,875 | 2,805 | 1,267 | 2,763 | N/A |
| 12/31/2023 | 13,740 | 2,701 | 1,114 | 2,439 | N/A |
| 9/30/2023 | 13,399 | 2,469 | 1,376 | 2,504 | N/A |
| 6/30/2023 | 13,059 | 2,236 | 1,637 | 2,568 | N/A |
| 3/31/2023 | 12,197 | 1,909 | 1,444 | 2,300 | N/A |
| 12/31/2022 | 11,334 | 1,581 | 1,251 | 2,031 | N/A |
| 9/30/2022 | 10,750 | 1,288 | 1,066 | 1,683 | N/A |
| 6/30/2022 | 10,166 | 995 | 882 | 1,336 | N/A |
| 3/31/2022 | 9,935 | 991 | 968 | 1,439 | N/A |
| 12/31/2021 | 9,703 | 988 | 1,055 | 1,543 | N/A |
| 9/30/2021 | 9,445 | 1,056 | 1,047 | 1,647 | N/A |
| 6/30/2021 | 9,187 | 1,123 | 1,039 | 1,752 | N/A |
| 3/31/2021 | 8,980 | 913 | 1,035 | 1,660 | N/A |
| 12/31/2020 | 8,772 | 703 | 1,030 | 1,568 | N/A |
| 9/30/2020 | 8,690 | 626 | 1,128 | 1,625 | N/A |
| 6/30/2020 | 8,607 | 549 | 1,226 | 1,683 | N/A |
| 3/31/2020 | 8,500 | 595 | 1,293 | 1,742 | N/A |
| 12/31/2019 | 8,393 | 642 | 1,361 | 1,801 | N/A |
| 9/30/2019 | 8,100 | 765 | 1,147 | 1,618 | N/A |
| 6/30/2019 | 7,808 | 888 | 932 | 1,436 | N/A |
| 3/31/2019 | 7,659 | 785 | 806 | 1,324 | N/A |
| 12/31/2018 | 7,511 | 683 | 681 | 1,213 | N/A |
| 9/30/2018 | 7,395 | 373 | 640 | 1,104 | N/A |
| 6/30/2018 | 7,280 | 64 | 599 | 995 | N/A |
| 3/31/2018 | 7,053 | 73 | N/A | 883 | N/A |
| 12/31/2017 | 6,827 | 82 | N/A | 770 | N/A |
| 9/30/2017 | 6,640 | -34 | N/A | 957 | N/A |
| 6/30/2017 | 6,454 | -150 | N/A | 1,144 | N/A |
| 3/31/2017 | 6,266 | -211 | N/A | 1,109 | N/A |
| 12/31/2016 | 6,078 | -272 | N/A | 1,074 | N/A |
| 9/30/2016 | 6,083 | -216 | N/A | 976 | N/A |
| 6/30/2016 | 6,076 | -159 | N/A | 875 | N/A |
| 3/31/2016 | 6,195 | -32 | N/A | 1,182 | N/A |
| 12/31/2015 | 6,446 | 92 | N/A | 1,516 | N/A |
| 9/30/2015 | 6,597 | 148 | N/A | 1,522 | N/A |
| 6/30/2015 | 6,711 | 201 | N/A | 1,521 | N/A |
| 3/31/2015 | 6,565 | 373 | N/A | 1,460 | N/A |
| 12/31/2014 | 6,422 | 545 | N/A | 1,400 | N/A |
| 9/30/2014 | 6,179 | 552 | N/A | 1,436 | N/A |
| 6/30/2014 | 6,101 | 574 | N/A | 1,511 | N/A |
| 3/31/2014 | 6,112 | 306 | N/A | 1,347 | N/A |
| 12/31/2013 | 5,972 | 38 | N/A | 1,155 | N/A |
Analist Gelecek Büyüme Tahminleri
Kazançlar ve Tasarruf Oranları: 3933 'nin tahmini kazanç büyümesi (yıllık 3.9% ) tasarruf oranının ( 2.3% ) üzerindedir.
Kazançlar ve Piyasa: 3933 şirketinin kazançlarının (yıllık 3.9% ) Hong Kong pazarından (yıllık 11.6% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Kazançları: 3933 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.
Gelir ve Pazar: 3933 şirketinin gelirinin (yıllık 6.1% ) Hong Kong pazarından (yıllık 7.8% ) daha yavaş büyümesi öngörülüyor.
Yüksek Büyüme Geliri: 3933 şirketinin gelirinin (yıllık 6.1% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.
Hisse Başına Kazanç Büyüme Tahminleri
Gelecekteki Özkaynak Getirisi
Gelecekteki ROE: 3933 'nin Özsermaye Getirisi'nin 3 yıl içinde düşük olması tahmin ediliyor ( 19.5 %).